Back to search

Article

Efficacy of Tecovirimat and Cidofovir Against MPXV-Induced Pneumonia, Skin Lesion, and Arthritis in the High-Risk Population-Relevant SCID Mouse Model

2025-04-23

Abstract excerpt

<title>Abstract</title> <p> On February 27, 2025, WHO maintained monkeypox as a PHEIC following its third round of assessment. Human monkeypox virus infection primarily manifests with fever, lymphadenopathy, and rash. Severe cases may develop pneumonia, encephalitis, myocarditis and arthritis. After evaluation of three murine models (ICR, IFNAR1 <sup>−/−</sup> , and SCID), we identified SCID mice as stable hos...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0cea3c52-086a-5b4e-a549-1fe945ce8bc7
DOI
10.21203/rs.3.rs-6483910/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of Tecovirimat and Cidofovir Against MPXV-Induced Pneumonia, Skin Lesion, and Arthritis in the High-Risk Population-Relevant SCID Mouse ModelDOI 10.21203/rs.3.rs-6483910/v1
Select a neighboring publication to make it the new centre.